Ping An Biomedical income statement data for the quarter ended Sep 2025. This income statement covers 3 quarters of results from Sep 2024 through Sep 2025, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2024 | Mar2025 | Sep2025 |
|---|---|---|---|
| Additional items | |||
| Shares Outstanding | 18.00M | 18.00M | 18.48M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 18.00M | 18.00M | 18.48M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 18.00M | 20.50M |